| Michael E Dunham, MD | |
|
4950 Essen Ln Ste 400, Baton Rouge, LA 70809-3738 | |
| (225) 765-1765 | |
| (225) 765-1768 |
| Full Name | Michael E Dunham |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 4950 Essen Ln Ste 400, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427025675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | MD.207839 (Louisiana) | Secondary |
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | C52086 (California) | Primary |
| Entity Name | Louisiana State University School Of Med In New Orleans Faculty Grou |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932492626 PECOS PAC ID: 9739358722 Enrollment ID: O20110810000538 |
News Archive
Health care education researchers, led by Dr. Julian Archer from Plymouth University Peninsula Schools of Medicine and Dentistry, have penned a heartfelt editorial in The BMJ calling for more research funding to support the evidence base for medical training.
Low sexual desire is common among both pre- and post-menopausal women. It can cause personal distress, harm relationships, and have a negative impact on body image and self confidence. Yet few women seek medical care for this condition, and the reasons are explored in a timely article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Research over decades has implicated aberrant autophagy and lysosomal function as reliable markers and therapeutic targets for neurodegenerative diseases.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
IBM today announced a new Research collaboratory, located in Taipei, Taiwan. The collaboratory will focus on using technologies - including cloud computing, analytics and mobile devices - to advance wellness-centric healthcare that manages diseases more efficiently and effectively to keep people healthier.
› Verified 9 days ago
| Entity Name | Our Lady Of The Lake Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033494943 PECOS PAC ID: 4587849781 Enrollment ID: O20120529000377 |
News Archive
Health care education researchers, led by Dr. Julian Archer from Plymouth University Peninsula Schools of Medicine and Dentistry, have penned a heartfelt editorial in The BMJ calling for more research funding to support the evidence base for medical training.
Low sexual desire is common among both pre- and post-menopausal women. It can cause personal distress, harm relationships, and have a negative impact on body image and self confidence. Yet few women seek medical care for this condition, and the reasons are explored in a timely article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Research over decades has implicated aberrant autophagy and lysosomal function as reliable markers and therapeutic targets for neurodegenerative diseases.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
IBM today announced a new Research collaboratory, located in Taipei, Taiwan. The collaboratory will focus on using technologies - including cloud computing, analytics and mobile devices - to advance wellness-centric healthcare that manages diseases more efficiently and effectively to keep people healthier.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael E Dunham, MD 7060 N Recreation Ave, Suite 101, Fresno, CA 93720-8022 Ph: (559) 916-3406 | Michael E Dunham, MD 4950 Essen Ln Ste 400, Baton Rouge, LA 70809-3738 Ph: (225) 765-1765 |
News Archive
Health care education researchers, led by Dr. Julian Archer from Plymouth University Peninsula Schools of Medicine and Dentistry, have penned a heartfelt editorial in The BMJ calling for more research funding to support the evidence base for medical training.
Low sexual desire is common among both pre- and post-menopausal women. It can cause personal distress, harm relationships, and have a negative impact on body image and self confidence. Yet few women seek medical care for this condition, and the reasons are explored in a timely article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Research over decades has implicated aberrant autophagy and lysosomal function as reliable markers and therapeutic targets for neurodegenerative diseases.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
IBM today announced a new Research collaboratory, located in Taipei, Taiwan. The collaboratory will focus on using technologies - including cloud computing, analytics and mobile devices - to advance wellness-centric healthcare that manages diseases more efficiently and effectively to keep people healthier.
› Verified 9 days ago
Stanley E. Peters, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Ste. 2121, Baton Rouge, LA 70810 Phone: 225-767-7200 Fax: 225-767-7386 | |
Samuel Ralph Barber, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd Ste 709, Baton Rouge, LA 70808 Phone: 225-765-7735 Fax: 225-765-9937 | |
Collin Blake Sutton, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-408-6900 | |
Dr. Christian A. Hall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8585 Picardy Ave, Ste 512, Baton Rouge, LA 70809 Phone: 225-819-1181 Fax: 225-636-5900 | |
Dr. Frank L. Fazio, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-769-2222 Fax: 225-766-2068 | |
Dr. Warner Lee Bruner Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 710 Colonial Dr, Baton Rouge, LA 70806 Phone: 225-927-5325 Fax: 225-927-4150 | |
Anna Maria Pou, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4950 Essen Ln, Mbperkins, 4th Floor, Suite A, Baton Rouge, LA 70809 Phone: 225-765-1765 Fax: 225-765-1768 |